Sanofi's Acomplia already copied in India: paper
680868
Sanofi-Aventis's anti-obesity drug Acomplia is facing three generic competitors in India even before it has won full approval from some markets, Les Echos newspaper reported on Thursday.
693990
Intensive-care doctors monitor patients from miles away. Also: Vioxx might be responsible for more deaths than thought.... New network in southern India gives government a big boost.... and more.
670417
PARIS Sanofi-SynthÃ©labo, which this month completed its $63 billion purchase of a rival drug manufacturer, Aventis, reported Tuesday a 21 percent jump in first-half profit on higher demand for the blood thinner Plavix and the cancer treatment Eloxatin.
549669
The same brand names are sometimes used for different drugs in different countries, posing a risk for people who import cheaper medicines from abroad, a U.S. group warned on Thursday.
450170
Plus: Was Einstein a plagiarist? [News.com Extra]
494319
Two generic AIDS treatments by Indian manufacturer Cipla have been reinstated on the World Health Organisation&#39;s recommended list, six months after they were removed for further testing.
73965
Viagra, the impotence pill that is copied and counterfeited around the world, is one of the first drugs to get a radio tracking device under a new FDA initiative announced Monday.
26459
Drugmaker Sanofi-Aventis , the target of a lawsuit seeking class-action status filed on behalf of shareholders, on Friday vowed to fight allegations it hid the side-effects of its anti-obesity drug Acomplia.
539847
GENEVA - India&#39;s Hetero Drugs is withdrawing six of its generic versions of antiretroviral drugs from the World Health Organization&#39;s list of approved HIV medicines, saying it is not certain they are biologically the same as the patented drugs.
257995
Brazil says it intends to copy patented anti-Aids drugs without permission from next year.
225538
Another Indian pharmaceutical company, Hetero Drugs, has withdrawn its generic anti-AIDS drugs from special World Health Organisation certification amid doubts about tests designed to prove their effectiveness, the UN health agency said.
667206
30/08/2004 A new miracle drug for obesity could prove central to the fortunes of manufacturer Sanofi-Aventis, a newly-merged firm, if the French company is successful in bringing it to the market.
310131
Aventis, part of the sanofi-aventis Group (EURONEXT: SAN), announced today that The New England Journal of Medicine has published the results of two landmark phase III studies, which demonstrate that Taxotere (docetaxel) Injection Concentrate-based
452895
Cape Town - An Indian pharmaceutical company has withdrawn 10 of its generic Aids drugs citing flaws in the research, the Science and Development Network reports.
736697
Ranbaxy Laboratories, India&#39;s biggest pharmaceuticals company, has ended its partnership with a clinical research organisation whose data for Ranbaxyâs generic anti-Aids drugs raised doubts about the authenticity of the medicines.
365874
Sanofi&#39;s Acomplia lowers cholesterol, trims waistlines, and blocks brain receptors associated with overeating. On the market by 2006?
186774
Will the product patents regime lead to unsustainably high drug prices? A demonstration against patenting of drug products in Chennai.